Number of the records: 1
Cotargeting of BCL2 with Venetoclax and MCL1 with S63845 Is Synthetically Lethal In Vivo in Relapsed Mantle Cell Lymphoma
- 1.
SYSNO 0579078 Title Cotargeting of BCL2 with Venetoclax and MCL1 with S63845 Is Synthetically Lethal In Vivo in Relapsed Mantle Cell Lymphoma Author(s) Průková, D. (CZ)
Anděra, Ladislav (UMG-J) [37] RID
Nahácka, Zuzana (UMG-J)
Karolová, J. (CZ)
Svaton, M. (CZ)
Klánová, M. (CZ)
Havránek, O. (CZ)
Soukup, J. (CZ)
Svobodová, K. (CZ)
Zemanová, Z. (CZ)
Tušková, D. (CZ)
Pokorná, E. (CZ)
Helman, K. (CZ)
Forsterova, K. (CZ)
Pacheco-Blanco, M. (CZ)
Vočková, P. (CZ)
Berková, A. (CZ)
Froňková, E. (CZ)
Trněný, M. (CZ)
Klener, P. (CZ)Corespondence/senior Klener, P. - Korespondující autor Source Title Clinical Cancer Research. Roč. 25, č. 14 (2019), s. 4455-4465. - : American Association for Cancer Research Document Type Článek v odborném periodiku Institutional support UMG-J - RVO:68378050 Language eng Country US Keywords acute myeloid-leukemia * open-label * cancer * landscape * combination * cytarabine * resistance * apoptosis * overcome * abt-199 URL https://aacrjournals.org/clincancerres/article/25/14/4455/81919/Cotargeting-of-BCL2-with-Venetoclax-and-MCL1-with Permanent Link https://hdl.handle.net/11104/0347951
Number of the records: 1